The short build that defined last week's note has already reversed — GLD closed at $414, up 0.6% on the week, and the bears who were quietly rebuilding positions through May 19 have since stood down.
The positioning shift is the clearest story this week. Short shares peaked at 10.55 million on May 19, the level flagged in last week's note as a trend reversal. Since then, they have fallen steadily to 9.61 million by May 26 — a 5.3% weekly decline that unwound the majority of that build in just five sessions. The month-on-month change sits at around 5%, so there is still slightly more short interest than there was in late April, but the directional momentum has flipped back. Shorts rebuilt, tested the $411 level, and retreated.
The options market is telling an even more striking story. Call-side positioning has moved to its most aggressive level in at least a year. The put/call ratio dropped to 0.543 on Tuesday — nearly three standard deviations below its 20-day average of 0.624, and the lowest reading in the past 52 weeks. The 52-week low for PCR is 0.391, so there is still room to run on the call side, but a z-score of nearly -3 is an unusual degree of options bullishness for an ETF that has spent most of the past year trading with a PCR comfortably above 0.60. Traders are leaning heavily into calls, not puts.
The lending market has loosened relative to where it was mid-month. Availability has climbed to around 207% of short interest, up roughly 20% on the week — meaning there is more than twice as much stock available to borrow as is currently borrowed. That is solidly in normal territory and provides no friction to new short-sellers. Borrow costs ticked up to 0.57% on the most recent reading, about 19% higher than a week ago, but remain low in absolute terms. The mid-month tightening — when availability dipped to around 155% and borrow costs briefly touched 0.63% — has eased.
The short score has drifted marginally lower over the past two weeks, from around 48.6 to 47.7. For context, a score near 50 is firmly mid-range — neither a strong short signal nor a strong squeeze signal. The score's flatness reinforces that this is not a high-conviction positioning environment in either direction. The ORTEX short score has barely moved despite the intraweek swings in actual short shares, suggesting the broader lending and positioning inputs remain balanced.
Institutional flows from the most recent Q1 filings show a mixed picture among the top holders. Morgan Stanley reduced its position by nearly 3 million shares to just over 10.9 million. JPMorgan and Goldman Sachs both added — JPMorgan by 860,000 shares, Goldman by nearly 290,000. UBS Asset Management added roughly 900,000 shares. The net institutional signal is not a one-way flow, but the additions from major banks coming into Q2 are worth noting alongside the current price action.
The analyst data for GLD is stale by several years and has been set aside. This is an ETF tracking physical gold, so the relevant inputs are macro and positioning rather than Street coverage.
What to watch: the PCR z-score near -3 is historically unusual for GLD — whether that extreme call positioning reflects genuine bullish conviction or near-term hedging of existing long positions into the next macro catalyst is the tension the next few sessions will clarify.
See the live data behind this article on ORTEX.
Open GLD on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
